Nuevocor
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Nuevocor Strengthens Board with Appointment of Thierry Abribat 2025-07-07 13:00
Nuevocor Announces FDA Clearance of IND for NVC-001 for LMNA-Related Dilated Cardiomyopathy 2025-06-10 16:49
Nuevocor Closes US$45 Million Series B Financing for Clinical Development of Novel Mechanobiology-Centered Therapy for Cardiomyopathy 2025-05-06 13:00
Nuevocor Welcomes Andreas Wallnöfer as Chairman of the Board of Directors 2025-01-24 22:00
Nuevocor Strengthens Leadership Team with Appointment of John Lee as Chief Medical Officer 2024-04-11 14:59
Nuevocor presents pre-clinical data at ESGCT and AHA meetings 2023-11-07 22:00
Nuevocor to Present at Biotech Showcase during JPM week and at Keystone Symposium on Heart Development and Disease 2022-12-21 22:00
Nuevocor to Present Pre-clinical Data on its Gene Therapy Candidate for LMNA Dilated Cardiomyopathy at American Heart Association Scientific Sessions 2022 2022-10-28 22:30
Nuevocor closes US$24M Series A Financing to Advance Novel Gene Therapies for Cardiomyopathies 2021-06-18 09:58
1